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Background
Diffuse myocardial fibrosis may be quantified with cardi-
ovascular magnetic resonance (CMR) by calculating
extra-cellular volume (ECV) from native and post-con-
trast T1 values. Previous studies have used either infu-
sion or single bolus contrast administration. In clinical
practice however split dose contrast injection is used as
part of a stress/rest protocol in stress perfusion studies.
The effects of using such an injection regime on ECV
calculation is unknown.
This study aimed to assess the effects of split dose versus
single bolus contrast administration on ECV calculation.
Methods
Ten healthy volunteers were studied on a 3.0 Tesla (Phi-
lips Achieva TX) MR system and underwent three sepa-
rate CMR studies over a mean of 30 days. In one study,
contrast was administered as a single bolus (Gadovist
0.15mmol/kg). In two further CMR studies, contrast was
given in two boluses (0.075mmol/kg per bolus) as part of
an adenosine stress/rest perfusion protocol, separated by
12 minutes. T1 maps were acquired pre contrast and 15
minutes following the single bolus or second contrast
injection. T1 measurements were made in the inter-ventri-
cular septum. Means and standard deviations were com-
pared between MOLLI T1 estimates and ECV calculated.
Results
Volunteer mean age was 27 ± 3yrs, BSA corrected
LVEDV (101 ± 12ml/m2) and LV mass (52 ± 7 g/m2)
were normal. No perfusion defects or scar were identi-
fied in the 10 volunteers. ECV agreed between bolus
and split dose contrast administration (coefficient of
variability 5.78%, bias -0.993, 95% CI -4.495 to 2.509,
r2=0.801, p>0.001)(figure 1). Inter-study agreement with
split dose administration was good (coefficient of varia-
bility, 5.67%, bias -0.018, 95% CI -4.045 to 4.009,
r2=0.766, p>0.001)(figure 2).
Conclusions
ECV quantification using split dose contrast administra-
tion is reproducible and in healthy controls agrees well
with previously validated methods. This suggests that
perfusion CMR studies may incorporate assessment of
tissue composition by ECV based on T1 mapping.
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Figure 1 Bland Altman plot of agreement between ECV estimated using single bolus and split-dose contrast administrations (bias -0.993, 95% CI
-4.495 to 2.509, r2=0.801, p=0.00).
Figure 2 Bland Altman plot of agreement of ECV estimates between visit 1 and 2 using split-dose administration (bias -0.018, 95% CI -4.045 to
4.009, r2=0.766, p=0.00)
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